Sean McClain is the founder of AbSci. AbSci has raised $525M in total funding. Latest round: IPO. Backed by Phoenix Venture Partners.
Sean McClain is the Founder and CEO of AbSci, a generative AI drug creation company he started in 2011 to unify biologic drug discovery using synthetic biology and E. coli. He has raised over $525 million for AbSci and led the company through an initial public offering.
Full founder directory · Investor directory · Company funding database · Fundraising library